TORONTO/MELBOURNE, August 1st, 2018 The Cell Care international cord blood banking group (“Cell Care”) – comprising Insception Lifebank and Cells for Life in Canada – today announced a strategic investment in ExCellThera Inc., a leading Montreal-based biotechnology company delivering molecules and bioengineering solutions to expand blood stem cells for therapeutic use. The investment and associated
Read MoreGrand River Hospital increases cord blood educational resources for new moms A new partnership announced between Grand River Hospital (GRH) and Insception Lifebank cord blood bank will provide additional educational resources to pregnant moms in Waterloo Region. GRH will feature Insception Lifebank’s educational information on the hospital’s website as well as in patient care areas within
Read MoreInsception Biosciences Inc. joins with Cell Care to Establish Global Platform Insception Lifebank, Canada’s largest private cord blood & tissue bank has today announced it has joined with Cell Care, Australia’s largest cord blood bank. The combined entity creates one of the world’s top 10 companies in the sector. Together, they store over 100,000 client
Read MoreJoint venture between Insception Lifebank, the Lunenfeld-Tanenbaum Research Institute and Ontario Centres of Excellence aims to develop iPSCs from cord blood and cord tissue. Insception Lifebank Cord Blood Program (“Insception”) is excited to announce its collaboration with Dr. Ian Rogers, from the The Lunenfeld-Tanenbaum Research Institute, part of Sinai Health System, to develop clinical grade
Read MoreIn April 2016, Insception Lifebank released two more cord blood units (CBUs) for clinical trials in regenerative medicine. Both CBUs were shipped to Duke University Medical Center in Durham, North Carolina and used in two different clinical trials for Cerebral Palsy (CP). On April 12, the first child, born in Prince George, BC, was infused
Read MoreHealth Canada has approved the initiation of a Phase I/II clinical trial for ExCellThera’s lead product, ECT-100, for the expansion of hematopoietic stem cells (HSCs). The trial will begin early 2016 and will enroll up to 25 patients who require stem cell transplantation for the treatment of acute myeloid leukemia (AML) and other malignant blood disorders with no
Read MoreNolan Laberge had acute myeloid leukemia, an aggressive type of blood cancer. After several rounds of chemotherapy, Nolan received a stem cell transplant in May 2012. Nolan was deemed cured almost immediately after the transplant.
Read MoreNolan Laberge had acute myeloid leukemia, an aggressive type of blood cancer. After several rounds of chemotherapy, Nolan received a stem cell transplant in May 2012. Nolan was deemed cured almost immediately after the transplant.
Read MoreThanks to the federal government’s $114-million grant, Toronto has been firmly established as the leader of the pack when it comes to centers for the design and manufacture of cells, tissues and organs used to treat degenerative disease.
Read MoreTake the first step to learn about cord blood and cord tissue today! Request your get info pack.
DownloadWe’re here to help!
Call Us:
Toll Free: 1-866-606-2790
电话: 1-888-268-1888
Email Us:
info@Insception.com
Join us for an informative session, either in person or online. We also offer tours at our Mississauga location.
Learn MoreEnroll today! Our convenient online process only takes about 15 minutes.
Enroll